Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Targeting ion channels for the treatment of autoimmune neuroinflammation.
JCV epidemiology in MS (JEMS)-Epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients-Portuguese data.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
Oligodendrogenesis in the normal and pathological central nervous system.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Role of puberty in multiple sclerosis risk and course.
Very Frequent Fallers and Future Fall Injury: Continuous Risk Among Community-Dwelling Home Care Recipients.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.
Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Revised diagnostic criteria of multiple sclerosis.
Self-report versus performance measure in gauging level of function with multiple sclerosis.
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.
[Difficulties experienced at work by patients with multiple sclerosis].
Pages
« first
‹ previous
…
398
399
400
401
402
403
404
405
406
…
next ›
last »